Vimarsana
Biggest News Aggregation in the World

Page 7 - Take Shape News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Take Shape. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Take Shape Today - Breaking & Trending Today

Medifast (NYSE:MED) Stock Rating Upgraded by StockNews.com - Vimarsana News

Medifast (NYSE:MED) Stock Rating Upgraded by StockNews.com

Medifast (NYSE:MED – Get Free Report) was upgraded by investment analysts at StockNews.com from a “hold” rating to a “buy” rating in a research note issued on Monday. Separately, DA Davidson cut their price objective on shares of Medifast from $93.00 to $80.00 and set a “neutral” rating on the stock in a report on […]

Code Orange Share Video For New Single Mirror - Vimarsana News

Code Orange Share Video For New Single Mirror

Photo: Tim Saccenti Code Orange have dropped a video for their new single Mirror....

Code Orange Share Emotive New Single 'Mirror' - Vimarsana News

Code Orange Share Emotive New Single 'Mirror'

Code Orange are showing a completely different side to their game on the latest cut from their forthcoming album. Have a listen now.

Rice Hall James & Associates LLC Cuts Stock Holdings in Medifast, Inc. (NYSE:MED) - Vimarsana News

Rice Hall James & Associates LLC Cuts Stock Holdings in Medifast, Inc. (NYSE:MED)

Rice Hall James & Associates LLC cut its stake in shares of Medifast, Inc. (NYSE:MED – Free Report) by 57.8% in the 1st quarter, Holdings Channel reports. The institutional investor owned 113,468 shares of the specialty retailer’s stock after selling 155,629 shares during the quarter. Rice Hall James & Associates LLC’s holdings in Medifast were […]

StockNews.com Lowers Medifast (NYSE:MED) to Hold - Vimarsana News

StockNews.com Lowers Medifast (NYSE:MED) to Hold

Medifast (NYSE:MED – Get Free Report) was downgraded by analysts at StockNews.com from a “buy” rating to a “hold” rating in a research note issued to investors on Wednesday. Separately, DA Davidson lowered their price objective on Medifast from $93.00 to $80.00 and set a “neutral” rating for the company in a research note on […]